TRPC6の薬理的な活性化は心不全を改善する
-
- Chenlin SU
- Graduate School of Pharmaceutical Sciences, Kyushu University
-
- Xinya MI
- Graduate School of Pharmaceutical Sciences, Kyushu University
-
- Yuri KATO
- Graduate School of Pharmaceutical Sciences, Kyushu University
-
- Akiyuki NISHIMURA
- National Institute for Physiological Sciences (NIPS) and Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences (NINS)
-
- Keitaro UMEZAWA
- Tokyo Metropolitan Institute for Geriatrics and Gerontology
-
- Yasuteru URANO
- Graduate School of Pharmaceutical Sciences & Medicine, The University of Tokyo
-
- Ryu NAGATA
- Graduate School of Pharmaceutical Sciences, Osaka University
-
- Yasuo MORI
- Graduate School of Engineering, Kyoto University
-
- Takaaki AKAIKE
- Graduate School of Medicine, Tohoku University
-
- Motohiro NISHIDA
- Graduate School of Pharmaceutical Sciences, Kyushu University National Institute for Physiological Sciences (NIPS) and Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences (NINS)
書誌事項
- タイトル別名
-
- Pharmacological activation of TRPC6 channels improves heart failure
説明
<p>A growing body of evidence suggests that transient receptor potential canonical (TRPC) 3 and 6 channels are involved in developing pathological remodeling of the heart. However, we found that activation of TRPC6 channel enhances β adrenoceptor (βAR)-stimulated myocardial positive inotropy and prevents chronic heart failure in mice by enhancing Zn2+ dynamics. This study aims to investigate whether TRPC6-mediated Zn2+ influx suppresses sympathetic overactivity-induced chronic heart failure in mice. </p><p>Chronic stimulation of βAR with isoproterenol (ISO; 30 mg/kg/day) for 4 weeks caused myocardial dysfunction in WT mice and Zn2+ permeation-dead (PD) TRPC6 mutant-expressing mice. Treatment with 2-[4-(2,3-dimethylphenyl)-piperazin-1-yl]-N- (2-ethoxyphenyl) acetamide (PPZ2), a TRPC3/6/7 channel activator, improved ISO-induced heart failure in WT mice but failed in TRPC6 (PD) mice. Zinpyr-1 imaging revealed that PPZ2 increased the intracellular Zn2+ pool in ISO-treated WT hearts, while this increase was not observed in ISO-treated TRPC6 (PD) hearts. In addition, the electrophysiological study demonstrated that TRPC6 (PD) mutant could permeate Na+, Ca2+ and K+ as much as WT, but failed to permeate Zn2+ after PPZ2 stimulation. PPZ2 improved ISO-induced impairment of L-type Ca2+ channel current. Furthermore, PPZ2 attenuated ISO-induced oxidative stress and supersulfide catabolism. In conclusion, these results suggest that activating TRPC6-mediated Zn2+ influx improves chronic heart failure by maintaining redox homeostasis.</p>
収録刊行物
-
- 日本毒性学会学術年会
-
日本毒性学会学術年会 51.1 (0), P-4S-, 2024
日本毒性学会